{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:57:31Z","timestamp":1764997051110,"version":"3.37.3"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["UM1 AI068634, UM1 AI068636, and UM1 AI106701"],"award-info":[{"award-number":["UM1 AI068634, UM1 AI068636, and UM1 AI106701"]}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["UM1 AI069463, UM1 AI069438, UM1 AI068632, UM1 AI069432, UM1 AI069477, UM1 AI069481 and UM AI069423"],"award-info":[{"award-number":["UM1 AI069463, UM1 AI069438, UM1 AI068632, UM1 AI069432, UM1 AI069477, UM1 AI069481 and UM AI069423"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2015,10,15]]},"DOI":"10.1093\/cid\/civ464","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T20:39:44Z","timestamp":1436906384000},"page":"1322-1327","source":"Crossref","is-referenced-by-count":62,"title":["Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention"],"prefix":"10.1093","volume":"61","author":[{"given":"Anthony T.","family":"Podany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Swindells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet W.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thando","family":"Mwelase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khuanchai","family":"Supparatpinyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lerato","family":"Mohapi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance A.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney V.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"2015092521474540000_61.8.1322.1","unstructured":"World Health Organization. Global tuberculosis report 2013."},{"key":"2015092521474540000_61.8.1322.2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0394"},{"key":"2015092521474540000_61.8.1322.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"2015092521474540000_61.8.1322.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005136"},{"key":"2015092521474540000_61.8.1322.5","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"Centers for Disease Control Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"volume-title":"International standards for tuberculosis care","year":"2014","author":"TB CARE I","key":"2015092521474540000_61.8.1322.6"},{"key":"2015092521474540000_61.8.1322.7","unstructured":"Sanofi-Aventis: Priftin (rifapentine) [package insert] August 2007. Available at: http:\/\/products.sanofi.us\/priftin\/priftin.pdf. Accessed 15 January 2015."},{"key":"2015092521474540000_61.8.1322.8","first-page":"426","article-title":"Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I","volume":"3","author":"Keung","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2015092521474540000_61.8.1322.9","unstructured":"US Department of Health Human Services. Panel on antiretroviral therapy and medical management of HIV infected children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 2012. Available at: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PediatricGuidelines.pdf. Accessed 15 January 2013."},{"key":"2015092521474540000_61.8.1322.10","unstructured":"US Department of Health Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 12 February 2013. 2013. Available at: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf. Accessed 12 February 2013."},{"key":"2015092521474540000_61.8.1322.11","unstructured":"World Health Organization. Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013. Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/download\/en\/. Accessed 1 August 2013."},{"key":"2015092521474540000_61.8.1322.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7961"},{"key":"2015092521474540000_61.8.1322.13","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12119"},{"key":"2015092521474540000_61.8.1322.14","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101050-00011"},{"key":"2015092521474540000_61.8.1322.15","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19971215)16:23<2701::AID-SIM704>3.0.CO;2-1"},{"key":"2015092521474540000_61.8.1322.16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.clpt.6100282","article-title":"Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial","volume":"83","author":"Fletcher","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"2015092521474540000_61.8.1322.17","article-title":"ADAPT 5 user's guide:","volume-title":"pharmacokinetic\/pharmacodynamic systems analysis software","author":"D'Argenio","year":"2009"},{"key":"2015092521474540000_61.8.1322.18","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2003.22"},{"key":"2015092521474540000_61.8.1322.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200512-1953OC"},{"key":"2015092521474540000_61.8.1322.20","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328328d577"},{"key":"2015092521474540000_61.8.1322.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-001-0396-3"},{"key":"2015092521474540000_61.8.1322.22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02532-14"},{"key":"2015092521474540000_61.8.1322.23","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku110"},{"key":"2015092521474540000_61.8.1322.24","unstructured":"Lee L , Soon G , Chew N , Else L , Amara A , Knoo S . Differential induction of efavirenz metabolism by rifampin without and with isoniazid in healthy volunteers with CYP2B6 516GG and TT genotypes [abstract 516]. In: 20th Conference on Retroviruses and Opportunistic Infections, 2013:3\u20136."},{"key":"2015092521474540000_61.8.1322.25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ155"},{"key":"2015092521474540000_61.8.1322.26","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328360dbb4"},{"key":"2015092521474540000_61.8.1322.27","unstructured":"Sanofi-Aventis: Rifadin (rifampin) [package insert] June 2014."},{"key":"2015092521474540000_61.8.1322.28","doi-asserted-by":"publisher","DOI":"10.5414\/CP202079"},{"key":"2015092521474540000_61.8.1322.29","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl399"},{"key":"2015092521474540000_61.8.1322.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000196181.18916.9b"},{"key":"2015092521474540000_61.8.1322.31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit246"},{"key":"2015092521474540000_61.8.1322.32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu429"},{"key":"2015092521474540000_61.8.1322.33","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/8\/1322\/1070313\/civ464.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T17:09:30Z","timestamp":1503421770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,9,25]]},"published-print":{"date-parts":[[2015,10,15]]}},"alternative-id":["10.1093\/cid\/civ464"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ464","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published":{"date-parts":[[2015,6,16]]}}}